Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2022

View Archived Issues

Targeting NHE1 prevents lung fibrosis progression

TNK1 blockade is an approach for inhibiting tumor growth

Johns Hopkins University, the Lieber Institute describe new RNA polymerase inhibitors

Macrophage colony-stimulating factor 1 receptor inhibitors identified at Hutchison MediPharma

New Bruton tyrosine kinase inhibitors synthesized at Hutchison MediPharma

Merck & Co. divulges new ceramide glucosyltransferase inhibitors

Targeting menin-MLL1 interaction inhibits neuroblastoma growth

UCL Business synthesizes new TTR stabilizers

Propionate metabolism plays role in metastatic ability

Human neutralizing antibody against PUUV spike broadly protects rodent models against hantaviruses

QF-84139 ameliorates cardiac hypertrophy via AMPK activation

HDAC7 plays a role in glioblastoma multiforme and is a promising therapeutic target

CEPI awards funding to NEC for broadly protective betacoronavirus vaccine

ADAM17 inhibition alleviates COVID-19-associated cytokine storm in lung epithelial cells

OliX observes inhibition of target gene expression in monkey study of OLX-702-A

AffyXell collaborates with Biocytogen and KNTSC on in vivo models and testing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...